Cargando…

P1519: MULTICENTER STUDY OF SARS-COV-2 INFECTION IN PATIENTS WITH HEMATOLOGICAL DISEASE: VACCINATION, ANTIVIRAL THERAPY, RISK FACTORS, AND OUTCOMES IN TAIWAN

Detalles Bibliográficos
Autores principales: Wu, Huai-Chueh Gem, Chiu, Ling-Jung, Lin, Tung-Liang, Ong, Yuen-Chin, Kuo, Ming-Chung, Huang, Yen-Min, Wu, Jin-Hou, Shih, Hsuan-Jen, Chen, Ning-Chun, Hung, Yu-Shin, Chang, Hung, Wang, Ming-Chung, Kao, Hsiao-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430122/
http://dx.doi.org/10.1097/01.HS9.0000972956.13238.b4
_version_ 1785090880267354112
author Wu, Huai-Chueh Gem
Chiu, Ling-Jung
Lin, Tung-Liang
Ong, Yuen-Chin
Kuo, Ming-Chung
Huang, Yen-Min
Wu, Jin-Hou
Shih, Hsuan-Jen
Chen, Ning-Chun
Hung, Yu-Shin
Chang, Hung
Wang, Ming-Chung
Kao, Hsiao-Wen
author_facet Wu, Huai-Chueh Gem
Chiu, Ling-Jung
Lin, Tung-Liang
Ong, Yuen-Chin
Kuo, Ming-Chung
Huang, Yen-Min
Wu, Jin-Hou
Shih, Hsuan-Jen
Chen, Ning-Chun
Hung, Yu-Shin
Chang, Hung
Wang, Ming-Chung
Kao, Hsiao-Wen
author_sort Wu, Huai-Chueh Gem
collection PubMed
description
format Online
Article
Text
id pubmed-10430122
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104301222023-08-17 P1519: MULTICENTER STUDY OF SARS-COV-2 INFECTION IN PATIENTS WITH HEMATOLOGICAL DISEASE: VACCINATION, ANTIVIRAL THERAPY, RISK FACTORS, AND OUTCOMES IN TAIWAN Wu, Huai-Chueh Gem Chiu, Ling-Jung Lin, Tung-Liang Ong, Yuen-Chin Kuo, Ming-Chung Huang, Yen-Min Wu, Jin-Hou Shih, Hsuan-Jen Chen, Ning-Chun Hung, Yu-Shin Chang, Hung Wang, Ming-Chung Kao, Hsiao-Wen Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430122/ http://dx.doi.org/10.1097/01.HS9.0000972956.13238.b4 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Wu, Huai-Chueh Gem
Chiu, Ling-Jung
Lin, Tung-Liang
Ong, Yuen-Chin
Kuo, Ming-Chung
Huang, Yen-Min
Wu, Jin-Hou
Shih, Hsuan-Jen
Chen, Ning-Chun
Hung, Yu-Shin
Chang, Hung
Wang, Ming-Chung
Kao, Hsiao-Wen
P1519: MULTICENTER STUDY OF SARS-COV-2 INFECTION IN PATIENTS WITH HEMATOLOGICAL DISEASE: VACCINATION, ANTIVIRAL THERAPY, RISK FACTORS, AND OUTCOMES IN TAIWAN
title P1519: MULTICENTER STUDY OF SARS-COV-2 INFECTION IN PATIENTS WITH HEMATOLOGICAL DISEASE: VACCINATION, ANTIVIRAL THERAPY, RISK FACTORS, AND OUTCOMES IN TAIWAN
title_full P1519: MULTICENTER STUDY OF SARS-COV-2 INFECTION IN PATIENTS WITH HEMATOLOGICAL DISEASE: VACCINATION, ANTIVIRAL THERAPY, RISK FACTORS, AND OUTCOMES IN TAIWAN
title_fullStr P1519: MULTICENTER STUDY OF SARS-COV-2 INFECTION IN PATIENTS WITH HEMATOLOGICAL DISEASE: VACCINATION, ANTIVIRAL THERAPY, RISK FACTORS, AND OUTCOMES IN TAIWAN
title_full_unstemmed P1519: MULTICENTER STUDY OF SARS-COV-2 INFECTION IN PATIENTS WITH HEMATOLOGICAL DISEASE: VACCINATION, ANTIVIRAL THERAPY, RISK FACTORS, AND OUTCOMES IN TAIWAN
title_short P1519: MULTICENTER STUDY OF SARS-COV-2 INFECTION IN PATIENTS WITH HEMATOLOGICAL DISEASE: VACCINATION, ANTIVIRAL THERAPY, RISK FACTORS, AND OUTCOMES IN TAIWAN
title_sort p1519: multicenter study of sars-cov-2 infection in patients with hematological disease: vaccination, antiviral therapy, risk factors, and outcomes in taiwan
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430122/
http://dx.doi.org/10.1097/01.HS9.0000972956.13238.b4
work_keys_str_mv AT wuhuaichuehgem p1519multicenterstudyofsarscov2infectioninpatientswithhematologicaldiseasevaccinationantiviraltherapyriskfactorsandoutcomesintaiwan
AT chiulingjung p1519multicenterstudyofsarscov2infectioninpatientswithhematologicaldiseasevaccinationantiviraltherapyriskfactorsandoutcomesintaiwan
AT lintungliang p1519multicenterstudyofsarscov2infectioninpatientswithhematologicaldiseasevaccinationantiviraltherapyriskfactorsandoutcomesintaiwan
AT ongyuenchin p1519multicenterstudyofsarscov2infectioninpatientswithhematologicaldiseasevaccinationantiviraltherapyriskfactorsandoutcomesintaiwan
AT kuomingchung p1519multicenterstudyofsarscov2infectioninpatientswithhematologicaldiseasevaccinationantiviraltherapyriskfactorsandoutcomesintaiwan
AT huangyenmin p1519multicenterstudyofsarscov2infectioninpatientswithhematologicaldiseasevaccinationantiviraltherapyriskfactorsandoutcomesintaiwan
AT wujinhou p1519multicenterstudyofsarscov2infectioninpatientswithhematologicaldiseasevaccinationantiviraltherapyriskfactorsandoutcomesintaiwan
AT shihhsuanjen p1519multicenterstudyofsarscov2infectioninpatientswithhematologicaldiseasevaccinationantiviraltherapyriskfactorsandoutcomesintaiwan
AT chenningchun p1519multicenterstudyofsarscov2infectioninpatientswithhematologicaldiseasevaccinationantiviraltherapyriskfactorsandoutcomesintaiwan
AT hungyushin p1519multicenterstudyofsarscov2infectioninpatientswithhematologicaldiseasevaccinationantiviraltherapyriskfactorsandoutcomesintaiwan
AT changhung p1519multicenterstudyofsarscov2infectioninpatientswithhematologicaldiseasevaccinationantiviraltherapyriskfactorsandoutcomesintaiwan
AT wangmingchung p1519multicenterstudyofsarscov2infectioninpatientswithhematologicaldiseasevaccinationantiviraltherapyriskfactorsandoutcomesintaiwan
AT kaohsiaowen p1519multicenterstudyofsarscov2infectioninpatientswithhematologicaldiseasevaccinationantiviraltherapyriskfactorsandoutcomesintaiwan